Abstract

As the complexity of the pharmaceutical industry increases and with the current disruptive forces affecting it, there is an increasing need for suitably-qualified personnel. Universities must respond to the need for graduates with the appropriate skills and knowledge to enable the transformation and future growth of this industry. Restructuring educational offerings to focus on graduate attributes, such as analytical and critical thinking, collaboration and problem solving, creativity, flexibility and self-direction in the context of the pharmaceutical industry facilitates the changes needed for future growth and viability. This paper discusses the process of program transformation to enable the development of graduates who can respond to these challenges in the pharmaceutical industry.

Highlights

  • It is said that we live in a VUCA world: volatile, uncertain, complex and ambiguous; a scenario that can be applied across a number of industries including healthcare and education (Casey, 2014)

  • The starting point for the development of the revised program was to articulate the mission of the program, which is to produce graduates with the knowledge and skills to make a meaningful contribution to medicines research, development and access, working across the pharmaceutical industry, academia and government, with the goal of improving the health and wellbeing of the community

  • Authentic activities are designed into each course and include active learning and problem-based scenarios focussed on real life situations to develop problemsolving and critical thinking skills (Herrington et al, 2003)

Read more

Summary

Introduction

It is said that we live in a VUCA world: volatile, uncertain, complex and ambiguous; a scenario that can be applied across a number of industries including healthcare and education (Casey, 2014). The starting point for the development of the revised program was to articulate the mission of the program, which is to produce graduates with the knowledge and skills to make a meaningful contribution to medicines research, development and access, working across the pharmaceutical industry, academia and government, with the goal of improving the health and wellbeing of the community.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.